GEN - FTSE/JSE Africa Index Series - Bioscience Brands (South Africa): Shares in
JSE BIO
GEN
GEN - FTSE/JSE Africa Index Series - Bioscience Brands (South Africa): Shares in
Issue Update
FTSE/JSE Africa Index Series
Bioscience Brands (South Africa): Shares in Issue Update
11 September 2009
Following the receipt of updated shares in issue and shareholder information for
Bioscience Brands (South Africa, constituent) and notification from the Stock
Exchange, FTSE and the JSE announces the following changes:
INDEX CHANGE EFFECTIVE FROM START
OF TRADING
FTSE/JSE Africa Bioscience Brands (South 21 September 2009
AltX (J232) Africa, ZAE000115036, B0L7LF1)
will remain in the index with
an increased shares in issue
total of 2,418,571,980 and a
decreased investability
weighting of 50%.
FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients.
For further information or general enquiries please contact us at info@ftse.com
or indices@jse.co.za or call:
Client Services in UK: Tel: +44 (0) 20 7866 1810
Client Services in Europe, Middle East & Africa: Tel: +44 (0) 20 7866 1810
Client Services in US: Tel: +1 888 747 FTSE (3873)
or +1 212 641 6124
Client Services in Asia Pacific: Tel: +852 2230 5803 or
+65 6223 3738 or +81 3 3581
2811
JSE Limited: Tel: (+27 11) 520 7106
or +520 7137
Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za
Date: 14/09/2009 07:08:01 Produced by the JSE SENS Department.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
